Description
Food supplement based on bromelina from Bromelami Retard, Devil's claw and boswellia. Flebase includes in its formulation an exclusive 2,500 GDU microencapsulated and gastroprotet (Bromelami Retard) to obtain a better tolerance with high bioavailability and a prolonged effect.
Suitable for vegans.

Ingredients
Devil's claw (Harpagophytum procumbens D.C., radix); bromelina gastroprotetta: Jams Retard [bromelina 2.500 GDU da Ananas comosus (L.) Merr., stipites, agenti di rivestimento (saccarosio, amido di mais, talco, gommalacca, idrossipropilcellulosa, maltodestrine)]; Boswellin Super: patented boswellia extract (Boswellia serrata Roxb., gummi-resina) titrated to 50% in boswellic acids and to 30% in AKBA, charge agent (microcrystalline cellulose), anti-agglomerating agents (silicon dioxide and magnesium stearate).
Without gluten and without lactose.

Nutritional characteristics

Average values	for 1 tablet
Bromelami Retard from pineapple Bromelina 2.500 GDU	500 mg 120 mg
Devil's claw	550 mg
Boswellin Super: dry boswellia extract Bosellic acids 50% AKBA* 30%	120 mg 60 mg 36 mg

*AKBA acid acetil-11 cheto-beta-boswellico

Mode of use
Take 1 tablet 3 times a day, preferably away from meals.

Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Food supplements should not be understood as substitutes for a varied and balanced diet and a healthy lifestyle.

Conservation
Store in a cool, dry place and away from light.
Validity of whole packaging: 24 months.

Format
60 tablets.
Net weight: 27 g.

Cod. SA.CPR.FLEBAS